Co-Authors
This is a "connection" page, showing publications co-authored by Vincent Enouf and Bruno Lina.
Connection Strength
0.828
-
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021. Euro Surveill. 2021 03; 26(9).
Score: 0.233
-
Performance of influenza case definitions for influenza community surveillance: based on the French influenza surveillance network GROG, 2009-2014. Euro Surveill. 2017 Apr 06; 22(14).
Score: 0.178
-
Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France. Lancet Reg Health Eur. 2021 Sep; 8:100171.
Score: 0.060
-
SARS-CoV-2 viral dynamics in non-human primates. PLoS Comput Biol. 2021 03; 17(3):e1008785.
Score: 0.058
-
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature. 2020 09; 585(7826):584-587.
Score: 0.056
-
Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020. Euro Surveill. 2020 04; 25(14).
Score: 0.055
-
Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 06; 20(6):697-706.
Score: 0.055
-
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro Surveill. 2020 03; 25(9).
Score: 0.054
-
Estimation of seasonal influenza vaccine effectiveness using data collected in primary care in France: comparison of the test-negative design and the screening method. Clin Microbiol Infect. 2018 Apr; 24(4):431.e5-431.e12.
Score: 0.046
-
First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro Surveill. 2013 Jun 13; 18(24).
Score: 0.034